Astrana Health, Inc. (ASTH)

Astrana Health, Inc. (ASTH) is a healthcare company (medical care facilities) based in the United States. The share price is $32.55, down 0.97% on the day, which values the company at $1.62B. Price as of 17 Nov 2026, 17:26 UTC, from Yahoo Finance.

Key facts

Share price
$32.55−0.97% today
Market value
$1.62B
P/E ratio
30.1×last 12 months
Forward P/E
9.3×
Funk Score
49/100
Against its own history
Well below its usual priceusual price $46.59
200-week average
$35.137% below
Sector
Healthcare

Figures as of . Prices from Yahoo Finance (may be delayed); statements from company filings with the SEC and Yahoo Finance. Estimates, not advice.

Astrana Health, Inc. in more detail

ASTH trades at 30.1× its last twelve months' earnings, 9.3× next year's expected earnings, 0.4× sales. Measured against its own history, the price is 30% below what its usual multiples would imply ($46.59) — well below its usual price. It sits 7% below its 200-week average of $35.13.

Over the last five fiscal years Astrana Health, Inc. has compounded revenue 35.9% a year, earnings per share -14.6% a year, free cash flow 18.4% a year. Its Funk Score is 49 out of 100 (financial strength 2.1, profitability 2.5, growth 7.7, value 7.3, each out of 10).

In its favour: Five straight years of revenue growth. Worth checking: Weak Piotroski score; Share count keeps rising.

1 of the superinvestors tracked here hold ASTH, including Diamond Hill team (0.2% of the portfolio).

Superinvestors holding ASTH

1 of the investors tracked here report a position in their latest 13F filing.

Astrana Health, Inc. (ASTH): questions and answers

What is ASTH's P/E ratio?

Astrana Health, Inc. trades at 30.1× its last twelve months' earnings and 9.3× next year's expected earnings. At its fiscal year-ends over the past 10 years the P/E ranged from 18.1× to 68.4×, with a median of 32.4×.

What is Astrana Health, Inc.'s market cap?

Astrana Health, Inc. is valued at $1.62B at a share price of $32.55.

Is ASTH overvalued or undervalued?

Against its own history, ASTH is well below its usual price: the price is 30% below the $46.59 implied by the median multiples it has traded at (price / earnings, price / sales, price / book, price / free cash flow). That compares the stock with its past; it does not say whether the business now deserves a higher or lower multiple.

Is ASTH above its 200-week moving average?

No. ASTH is 7.4% below its 200-week average of $35.13. Long-term investors watch that line because strong companies rarely trade below it for long.

How fast is Astrana Health, Inc. growing?

Over the last five fiscal years Astrana Health, Inc.'s revenue grew 35.9% a year and its earnings per share -14.6% a year; over ten years revenue grew 57.9% a year.

Does ASTH pay a dividend?

Astrana Health, Inc. does not currently pay a regular dividend.

Cite this page

Funkfolio, “Astrana Health, Inc. (ASTH) stock: price, valuation and fundamentals”, data as of 17 November 2026. https://funkfolio.com/stock/ASTH

Underlying data: Yahoo Finance; company filings with the SEC.